A Pilot Study to Explore the Role of Gut Flora in Multiple Sclerosis
NCT04148313 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Multiple Sclerosis.
Conditions
Interventions
- OTHER
-
No Intervention
There is no intervention for this study.
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis
NCT03975413 ·Status: COMPLETED
-
Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II
NCT03797937 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Microbiome in Multiple Sclerosis
NCT05844826 ·Status: TERMINATED ·Phase: NA
-
Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis
NCT04203017 ·Status: TERMINATED ·Phase: PHASE1
-
Retrospective Study on the Role of SCFA Modulation in Multiple Sclerosis
NCT06746896 ·Status: ACTIVE_NOT_RECRUITING
-
A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis
NCT01737372 ·Status: COMPLETED
-
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 ·Status: COMPLETED
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Immunodeficiency in MS
NCT04447937 ·Status: UNKNOWN
-
FMT for MS Patients
NCT04150549 ·Status: UNKNOWN ·Phase: PHASE2
-
Measuring Active Microglia in Progressive Multiple Sclerosis
NCT02207075 ·Status: COMPLETED
-
Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2
NCT06309173 ·Status: WITHDRAWN
-
A Systems Approach to Understanding Disease Processes in Multiple Sclerosis
NCT05081700 ·Status: COMPLETED
-
An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis
NCT02612935 ·Status: COMPLETED
-
Methionine Intake Microbiota
NCT07283328 ·Status: RECRUITING ·Phase: NA
-
Probiotic Intervention for People With Multiple Sclerosis
NCT07304713 ·Status: COMPLETED ·Phase: NA
-
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT04873492 ·Status: RECRUITING ·Phase: NA
-
Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.
NCT00630383 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Pilot Study of Lithium in Progressive Multiple Sclerosis
NCT01259388 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis Patients
NCT06220409 ·Status: COMPLETED ·Phase: NA
-
Pilot Diet Study for Multiple Sclerosis
NCT02986893 ·Status: COMPLETED ·Phase: NA
-
Gene Expression in MS Patients Before and During Treatment With Interferon-beta
NCT00202384 ·Status: TERMINATED
-
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
NCT01539395 ·Status: WITHDRAWN
-
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
NCT03177655 ·Status: COMPLETED ·Phase: NA
-
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
NCT03257358 ·Status: COMPLETED ·Phase: PHASE4